Low back pain is the leading cause of disability, with an estimated 632 million persons worldwide suffering and producing societal costs exceeding $100 billion annually in the United States. The use of low-level lasers (LLLT) has demonstrated beneficial effects for treating a range of painful musculoskeletal conditions, including low back pain. The Food and Drug Administration granted LLLT the first 510(k) market clearance for the treatment of chronic low back pain (K180197), based off a randomized, double-blind, sham-controlled study. The objective of the following study was to reassess the safety and efficacy of LLLT in these same subjects 12 months after receiving LLLT for chronic low back pain.
Berry TS, Quarneri PJ, Roche G, Sammons TM (2020) Low-Lever Laser Therapy for Treating Low Back Pain: 12-Month Follow-Up. J Pain Relief 9: 347.
